Journal of Medicinal Chemistry · 2014 · 82 citations · 16 references
PharmacyMedicinal ChemistryMolecular BiologyDrug DesignDrug DiscoveryStructural BiologyFragment-based Drug DesignFragment-based Lead DiscoveryHit DiscoveryTargeted Cancer TherapyBromodomain InhibitionBromodomain Protein TargetingBromodomain ProteinsFragment Hit ValidationFragment Library ScreeningFragment Screening LibrariesFragment-based Discovery
Cellular and genetic evidence suggest that inhibition of ATAD2 could be a useful strategy to treat several types of cancer. To discover small-molecule inhibitors of the bromodomain of ATAD2, we used a fragment-based approach. Fragment hits were identified using NMR spectroscopy, and ATAD2 was crystallized with three of the hits identified in the fragment screen.
16
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Suzanne B. Shuker, Philip J. Hajduk, Robert Meadows et al. · Science · 1996 · 2K citations
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
P. Filippakopoulos, S. Picaud, Maria Mangos et al. · Cell · 2012 · 1.8K citations · Full text
ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
Marco Cirò, Elena Prosperini, Micaela Quarto et al. · Cancer Research · 2009 · 244 citations · Full text